Urbanska, E.M.; Koffeldt, P.R.; Grauslund, M.; Melchior, L.C.; Sørensen, J.B.; Santoni-Rugiu, E.
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC. Int. J. Mol. Sci. 2025, 26, 5969.
https://doi.org/10.3390/ijms26135969
AMA Style
Urbanska EM, Koffeldt PR, Grauslund M, Melchior LC, Sørensen JB, Santoni-Rugiu E.
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC. International Journal of Molecular Sciences. 2025; 26(13):5969.
https://doi.org/10.3390/ijms26135969
Chicago/Turabian Style
Urbanska, Edyta Maria, Peter Rindom Koffeldt, Morten Grauslund, Linea Cecilie Melchior, Jens Benn Sørensen, and Eric Santoni-Rugiu.
2025. "Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC" International Journal of Molecular Sciences 26, no. 13: 5969.
https://doi.org/10.3390/ijms26135969
APA Style
Urbanska, E. M., Koffeldt, P. R., Grauslund, M., Melchior, L. C., Sørensen, J. B., & Santoni-Rugiu, E.
(2025). Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC. International Journal of Molecular Sciences, 26(13), 5969.
https://doi.org/10.3390/ijms26135969